The first multisociety guidelines on the diagnosis and management of acute pulmonary embolism feature a new classification ...
MedPage Today on MSN
Inhaled Vasodilator Slows Lung Function Decline in Idiopathic Pulmonary Fibrosis
Clinical worsening also occurred less frequently with treprostinil ...
Carla Bellucci, widely known as “Britain’s most hated woman,” has revealed she was diagnosed with a life-changing condition. The influencer gained notoriety in the past for saying she flirted with her ...
This chronic lung condition causes your airways to become permanently widened and scarred. Learn how to spot and treat this ...
An old anti-seizure drug might also work to reduce apnea episodes, recent trial data has shown. Millions of people in the U.S ...
BioVersys Announces First Patient Dosed in Phase 2b Clinical Trial of AlpE in Pulmonary Tuberculosis
Ad hoc announcement pursuant to Art. 53 LR BASEL, Switzerland, March 12, 2026 (GLOBE NEWSWIRE) -- Under the BioVersys and GSK collaboration agreement, AlpE clinical development advances with first ...
Daily Maverick on MSN
The silent scourge - why poverty drives chronic respiratory illnesses in South Africa
Chronic respiratory diseases such as asthma account for 4% of all deaths in South Africa and poverty is the main underlying driver of these diseases, say experts.
Chronic obstructive pulmonary disease (COPD) has become one of the world’s most lethal but least prioritised health crises. Each year, more than 3.5 million people die from COPD, a group of lung ...
Carla Bellucci, who became infamous after faking depression to get a free NHS nose job in 2019, has been diagnosed with COPD, ...
A highly contagious respiratory virus, HMPV, is spreading on the West Coast and beyond. Experts warn of symptoms, severe ...
A pulmonologist discusses the history and influence of race-based reference equations in pulmonary function testing interpretation and patient care.
A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate to severe sleep apnea. Patients taking higher doses experienced up to 47% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results